Omexa Formulary Private Limited

Omexa Formulary Private Limited - pharma in Bathinda, Punjab, India. Directors, charges & compliance details.
CIN U21001PB2023PTC058767 Incorporated 08 June 2023 ROC Chandigarh HQ Bathinda, Punjab, India
Active Private Limited Company pharma
Data last updated
Authorised capital
₹21.5 Cr
Registered with MCA
Paid-up capital
₹17.6 Cr
Issued & subscribed
Satisfied charges
₹1.37 Cr
No open charges
Company age
3 yrs
Est. 2023
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data

About Omexa Formulary Private Limited

Data last updated:

Omexa Formulary Private Limited is a private limited company based in Bathinda, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 June 2023.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U21001PB2023PTC058767.

The company has an authorised share capital of ₹21.5 Cr and a paid-up capital of ₹17.6 Cr. It is led by directors including Ekambaranathan Ramanathan and Ashu Singla.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bathinda, Punjab.

As per MCA filings, the company has satisfied charges of ₹1.37 Cr on record.

Company details

CIN U21001PB2023PTC058767
Registration Number 058767
Incorporation Date 08 June 2023
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Omexa Formulary Private Limited's registered office is in Bathinda, Punjab.

  • Registered Address
    No 1249 Near Water Tank, Phase – 3 Model Town, Bathinda, Punjab, India – 151001
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Omexa Formulary Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Omexa Formulary Private Limited

FY 2025 filings available

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Omexa Formulary Private Limited, buy the company report.

Board of directors of Omexa Formulary Private Limited

Omexa Formulary has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ekambaranathan RamanathanDirector08 Jun 20233 Years 4 MonthsCurrent
Ashu SinglaDirector09 Sep 20233 Years 1 MonthsCurrent
Nathan Kannan RamanathanDirector10 Oct 20233 Years 0 MonthsCurrent

Charges & borrowings

Open charges
None
Satisfied charges
₹1.37 Cr
Breakdown by lending institutions
Others₹1.37 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Oct 2023100804730Others₹1.37 CrSatisfied

To see the full charge records of Omexa Formulary Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Omexa Formulary Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Omexa Formulary Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Omexa Formulary Private Limited has 5 board changes on record since 2023: 4 appointments and 1 cessation. The latest: Nathan Kannan Ramanathan was appointed as Director on 10 Oct 2023.

AGM
Omexa Formulary Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Omexa Formulary Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge registered on 27 Oct 2023 via Charge ID 100804730 with Others was fully satisfied on 16 Mar 2024.
Charges
A charge with Others amounted to Rs. 1.37 Cr with Charge ID 100804730 was registered on 27 Oct 2023.
Appointed
Nathan Kannan Ramanathan was appointed as Director.
Ceased
Alka Bansal ceased to be Director.
Appointed
Ashu Singla was appointed as Director.
Appointed
Alka Bansal was appointed as Director.
Appointed
Ekambaranathan Ramanathan was appointed as Director.
Incorporation
08 Jun 2023
Omexa Formulary Private Limited was registered on 08 Jun 2023 with Roc Chandigarh & aged 3 years 4 months as per MCA records.

Frequently asked questions

Omexa Formulary is an active private limited company based in Bathinda, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 June 2023 (3+ years old) and is registered under CIN U21001PB2023PTC058767.

Omexa Formulary has 3 current directors:

The latest financial statements of Omexa Formulary on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Omexa Formulary is U21001PB2023PTC058767. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Omexa Formulary was incorporated on 08 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chandigarh.

Nathan Kannan Ramanathan was appointed as Director on 10 Oct 2023. Alka Bansal ceased to be Director on 10 Sep 2023. Ashu Singla was appointed as Director on 09 Sep 2023. Omexa Formulary has 5 board changes on record in total.

The registered office of Omexa Formulary is at No 1249 Near Water Tank, Phase – 3 Model Town, Bathinda, Punjab, India – 151001.

Omexa Formulary operates in the pharma industry, in the drug formulation and development segment.

Omexa Formulary has no open charges and satisfied charges of ₹1.37 Cr as per latest MCA filings.

Omexa Formulary can be reached at its registered office: No 1249 Near Water Tank, Phase – 3 Model Town, Bathinda, Punjab, India – 151001.